Study on Duodenal pulsENDO for Type II Diabetes and Liver Disease Initiated
A clinical trial is underway to assess the efficacy and safety of the pulsENDO procedure in patients with suboptimally controlled Type II Diabetes Mellitus and steatotic liver disease.